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Wistar ratsAbstract The aim of the present study was to investigate histological alterations of rat thyroid gland
after short-term treatment with supraphysiological doses of thyroid hormones. Rats from experimen-
tal groups were treated with triiodothyronine (T3) or thyroxine (T4) during ﬁve days. In both treated
groups, thyrocyte height was reduced and follicular lumens were distended. Progressive involutive
changes of the thyroid parenchyma were apparent, including follicular remodeling (fusion) and death
of thyrocytes. Morphological changes conﬁrmed by quantitative analysis were more pronounced in
the T4-treated group. Our results demonstrate that thyrotoxicosis, whether induced by T3 or T4,
leads to different grades of thyroid tissue injury, including some irreversible damages. These changes
might be explained at least in part by lack of trophic and cytoprotective effects of the thyroid stim-
ulating hormone. Since the period required for morphophysiological recovery may be unpredictable,
ﬁndings presented here should be taken into consideration in cases where the thyroid hormones are
used as a treatment for thyroid and non-thyroid related conditions.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Thyroid gland is specialized for production, storage and
release of thyroid hormones thyroxine (T4) and triiodothy-
ronine (T3). T4 is a quantitatively dominant hormone released
from the thyroid gland, while T3 is biologically more active
and originates mainly from peripheral deiodination of T4
(Boelaert and Franklyn, 2005). Thyroid hormones are
involved in regulation of metabolic rate and energy expendi-
ture in homeothermic animals (Cavalieri, 1997) and they are
necessary for normal cell growth and development (Silva,
1995).doses of
2 N.M. Ali Rajab et al.Biosynthesis and secretion of thyroid hormones are regu-
lated by hypothalamus-pituitary-thyroid axis, with the nega-
tive feedback loop at the level of both hypothalamus and
pituitary gland (Norman and Litwack, 1987; Williams and
Bassett, 2011). Namely, thyroid gland activity is positively reg-
ulated by thyroid stimulating hormone (TSH) synthesized and
secreted from pituitary thyrotrophs, which activity is in turn
controlled by hypothalamic TSH-releasing hormone (TRH).
Under physiological conditions, circulating thyroid hormones
suppress the release of TSH and TRH thus providing the so-
called long negative feedback loop regulating thyroid function.
In addition, there exist short and ultra-short feedback loops
represented by suppressive activity of TSH on both TRH
and TSH release (Prummel et al., 2004). A failure at any step
of this complex regulatory mechanism leads to dysregulation
of thyroid function, which is manifested as either hyper- or
hypoproduction of hormones and can cause serious health
problems in humans and companion animals. Normal produc-
tion of thyroid hormones also depends on an adequate supply
of iodine (Kelly, 2000).
Thyroid hormones are frequently used in human and veteri-
nary medicine as replacement therapy for thyroid deﬁciency
(Dixon et al., 2002; Escobar-Morreale et al., 2005;
Wiersinga, 2001) and, in doses slightly above physiological,
in therapy of differentiated thyroid carcinoma (Brabant,
2008). Supraphysiological doses of thyroid hormones are also
in use as supplemental therapy for some diseases and condi-
tions that are not associated with thyroid dysfunction such
as prophylaxis-resistant affective disorders (Bauer et al.,
2002) or Wilson’s temperature syndrome (Friedman et al.,
2006). Besides, some promising investigations regarding use
of supraphysiological doses of thyroid hormones for heart
repair after myocardial infarctation are in progress (Pantos
et al., 2009, 2008, 2007).
Data on possible side effects of such therapies in humans
are still inconsistent and vary depending on tissue, organ or
function examined. Despite the fact that hyperthyroidism is
commonly associated with insomnia, high doses of T4 used
for treatment of mood disorders did not cause sleep impair-
ment in otherwise healthy patients (Kraemer et al., 2011).
Also, it seems that supraphysiological doses of T4 are not nec-
essarily associated with bone mineral density loss even after a
very long period of treatment (Ricken et al., 2012; but see also
Chen et al., 2004). From the animal studies it is known that
experimentally induced thyrotoxicosis causes impairment of
some cognitive functions (Taskin et al., 2011) and activates h
ypothalamic–pituitary–adrenal axis thus potentially compro-
mising adrenal function (Johnson et al., 2005).
Given the wide use of thyroid hormones as therapeutics in a
number of diseases and conditions and rather good common
knowledge on their undesired effects on various organs, there
is a surprising paucity of studies dealing with the effects of sup-
raphysiological doses of thyroid hormones on the thyroid
gland.
Bearing in mind that the structure of any organ closely
reﬂects the state of its function, the aim of the present study
was to investigate the effects of treatment with supraphysiolog-
ical doses of T3 or T4 on histological and cytological charac-
teristics of thyroid gland in euthyroid animals. The obtained
results should contribute to better understanding of the possi-
ble side-effects and safety of therapy with high-doses of thy-
roid hormones.Please cite this article in press as: Ali Rajab, N.M. et al., Histological and ultrastructu
thyroid hormones. Saudi Journal of Biological Sciences (2015), http://dx.doi.org/102. Materials and methods
2.1. Animals
The experiment was performed on a total of 18 male Wistar
rats, weighing 180–250 g. Animals were caged individually,
at room temperature (22 ± 1 C), in 12:12 h light–dark cycle
and had free access to food (commercial rat food, Subotica,
Serbia) and tap water. Animal handling and treatment were
carried out in accordance with The Serbian Laboratory
Animal Protection Law proposed guidelines and protocols
approved by The Ethics Committee of the Faculty of
Biology, University of Belgrade.
2.2. Experimental design
The rats were divided into three equal groups and treated once
a day, for 5 days, as follows: T3-treated rats received injections
of T3 (200 lg/kg b.w.) dissolved in 9 mM NaOH; T4-treated
animals received T4 (300 lg/kg b.w.) dissolved in 9 mM
NaOH; control (euthyroid) animals were injected with vehicle
only (9 mMNaOH, 1 ml/kg b.w.). Body temperature was mea-
sured at the beginning and at the end of the experiment. In the
course of the experiment, all animals were in good health and
condition. After the last injection, body mass was measured
and rats were sacriﬁced by decapitation using a guillotine
(Harvard Apparatus, Holliston, MA, USA).
2.3. Determination of thyroid hormones in the circulation
For determination of T3 and T4 concentration in the serum,
blood samples were collected from the trunk during sacriﬁcing.
Total serum T3 and T4 concentrations were determined by the
RIA method, at the laboratory of The Institute for the
Application of Nuclear Energy (INEP, Belgrade, Serbia).
2.4. Processing of thyroids for light microscopy
After isolation and weighing, the left lobe of each thyroid
gland was routinely processed for light and the right one for
electron microscopy. For light microscopy, each thyroid lobe
was ﬁxed in 3.7% phosphate-buffered formalin (pH = 7.2),
dehydrated through an ethanol series and xylol and embedded
in parafﬁn. For general histological analysis, as well as for
stereological measurements, 5 lm thick parafﬁn sections
stained with hematoxylin/eosin method, taken from the ante-
rior, medial and posterior part of the thyroid lobe (ﬁve non-
serial sections per each chosen part of a lobe), were analyzed
on Leica DMLB light microscope (Wetzlar, Germany).2.5. Detection of cell death
Cell death was demonstrated by propidium iodide (PI) staining
method (Markelic et al., 2011; Scaglia et al., 1997). Brieﬂy,
deparafﬁnized and rehydrated 5 lm thick sections were stained
in 1% PI solution, for 10 min. Glycerol-mounted sections were
examined with a Zeiss Observer.Z1 ﬂuorescent microscope and
photographed with AxioCam MR3 camera, using AxioVision
Rel4.7 software. The occurrence of cell death was estimated by
counting normal and apoptotic nuclei in the follicular wall,ral alterations of rat thyroid gland after short-term treatment with high doses of
.1016/j.sjbs.2015.05.006
Table 1 Effect of treatment with T3 or T4 on thyroid
hormone serum levels, body temperature and absolute and
relative mass of thyroid gland.
Control T3-treated T4-treated
Serum T3
concentration
(nmol/l)
1.19 ± 0.074 1.69 ± 0.070** 1.87 ± 0.130**
Serum T4
concentration
(nmol/l)
133.7 ± 8.27 20.6 ± 3.10*** 289.3 ± 23.16***
Body temperature
change (C)
0.2 ± 0.10 0.4 ± 0.20 1.0 ± 0.26*
Absolute thyroid
gland mass (mg)
34.3 ± 8.46 28.6 ± 2.80 28.2 ± 3.90
Relative thyroid
gland mass
(mg/100 g b.w.)
13.7 ± 1.12 11.6 ± 0.95 11.3 ± 1.36
* p< 0.05 vs. control.
** p< 0.01 vs. control.
*** p< 0.001 vs. control.
Thyroid gland in hyperthyroidism 3using three non-serial sections per each chosen part of the thy-
roid lobe (as described above). Results are presented as per-
centage of apoptotic nuclei.
2.6. Processing of the thyroids for electron microscopy
After initial ﬁxation in 3.7% phosphate-buffered formalin, the
right lobe of each thyroid gland was thoroughly rinsed in tap
water, diced into small pieces (1 mm3) and ﬁxed in 2.5% glu-
taraldehyde in 0.1 M phosphate buffer, at pH 7.4, for 1 h. This
was followed by postﬁxation in 1% osmium-tetroxide in 0.1 M
phosphate buffer at pH 7.4, for 1 h. After dehydration through
a series of cold alcohols and propylene oxide, tissue samples
were embedded in Araldite. Ultrathin sections, gained after
selection from semi-ﬁne (1 lm), toluidine blue stained sections,
were cut on Leica EM UC6 (Leicamicrosystem, Wetzlar,
Germany), contrasted with uranyl acetate and lead-citrate
and examined with a Philips CM12 electron microscope
(Eindhoven, The Netherlands).
2.7. Stereological analysis
Stereological analysis was performed by the point-counting
method, using M42 multipurpose test grid, at a ﬁnal magniﬁca-
tion of 400·. Data obtained from 20 test ﬁelds of each sectioned
part of the thyroid lobe (parafﬁn embedded samples stained
with hematoxylin/eosin) served to calculate volume density of
particular phases (colloid, follicular epithelium, interfollicular
tissue) using standard equation Vvph = Pph/Ptot, where Pph is
number of points on a particular phase and Ptot is the total
number of points over tested area) (Weibel, 1979). Thyroid acti-
vation index (Ia) was expressed as the epithelial to colloid vol-
ume density ratio (Ia = Vve/Vvc) (Kalisˇnik, 1972). All fully
visible thyroid follicles seen on examined slides were included
in the determination of mean diameter of thyroid follicles,
which was calculated as (max transverse diameter + max
diameter perpendicular to the ﬁrst one)/2. Follicular cell height
was determined from toluidine blue-stained semi-thin sections
of plastic embedded tissue. Measurement was carried out on
300 cells per animal, having a clearly deﬁned nucleus, by the
use of a micrometer scale inserted into the ocular, at a magni-
ﬁcation of 1000·.
2.8. Statistical analysis
Statistical analysis for differences between control and each of
two experimental groups was performed using Student’s t-test.
Data were expressed as mean ± SEM. The level of signiﬁcance
was set at p< 0.05, 0.01 and 0.001.
3. Results
3.1. General effects of thyroid hormones
Results for thyroid hormone level, body temperature and
absolute and relative mass of the thyroid gland in control,
T3- and T4-treated rats are presented in Table 1.
After T3 treatment, level of T3 in circulation was increased
compared to the control (p< 0.01), while the level of T4 was
extremely reduced ( p< 0.001). Treatment with T4 signiﬁcantlyPlease cite this article in press as: Ali Rajab, N.M. et al., Histological and ultrastructu
thyroid hormones. Saudi Journal of Biological Sciences (2015), http://dx.doi.org/10.increased both T3 and T4 concentrations in circulation
(p< 0.01 and p< 0.001, respectively).
Mean body temperature of rats was elevated after both
treatments but with signiﬁcance recorded only in the T4-group.
Absolute and relative thyroid gland masses remained statis-
tically unchanged in both treated groups.
3.2. Thyroid hormone effects on histological organization of the
thyroid gland
Thyroid glands from control animals (Fig. 1a and d) showed
normal histological appearance, with cuboidal to low-
columnar epithelium lining small and medium-sized follicles,
and lower epithelium lining large follicles (arbitrary deter-
mined). Interstitium contained connective tissuewith blood cap-
illaries and individual or clustered parafollicular cells. InT3- and
T4-treated groups (Fig. 1b and e and Fig. 1c and f, respec-
tively), thyroid parenchyma appeared less well ordered. In both
treated groups, thyroid follicles were enlarged and seemed dis-
tended due to colloid accumulation. Follicles were lined mostly
with ﬂattened thyrocytes containing oval nuclei with increased
chromatin density. Epithelium of some large follicles was extre-
mely low, especially in T4-treated animals. Large follicles of
irregular shape suggesting disruption of follicular walls and
fusion of neighboring follicles (Fig. 1c, asterisk), as well as an
interfollicular barrier consisting of a single row of thyrocytes
(Fig. 1c, e and f, arrowhead), were also apparent. Inside the
lumen of some irregular follicles desquamated thyrocytes were
noticed (Fig. 1c, asterisk). The amount of interfollicular con-
nective tissue was reduced, and capillaries were collapsed.
3.3. Demonstration of cell death
Parafﬁn sections stained with PI served for demonstration of
apoptotic cell death. PI is a ﬂuorescent dye that binds to
nucleic acids in dead cells. Thus, all nuclei on tissue section
are stained, but the nuclei of cells that were dead at the
moment of ﬁxation appear opaque and show strongral alterations of rat thyroid gland after short-term treatment with high doses of
1016/j.sjbs.2015.05.006
Figure 1 Thyroid follicles from control (a and d), T3- (b and e) and T4-treated rats (c and f), parafﬁn (a–c, hematoxyline/eosin) and
plastic (d–f, toluidine-blue) embedded sections. Note thinning of the interfollicular barrier (arrowheads in c, e and f) and desquamated
thyrocytes within the follicular lumen (asterisk in c). Bar 10 lm (a–c) and 4 lm (d–f).
Figure 2 Percentage of PI-positive nuclei in thyroids of control
and TH treated animals. Percentages of PI-positive nuclei in
thyroids of T3-treated rats (7.1 ± 0.12, *p< 0.05) and T4-treated
rats (9.1 ± 0.44, **p< 0.01) were signiﬁcantly higher than in
control animals (3.7 ± 0.53).
4 N.M. Ali Rajab et al.ﬂuorescence (referred as PI-positive nuclei), and can be readily
discriminated from slightly transparent nuclei of cells that were
alive immediately before ﬁxation. Statistical analysis showed
that the percentage of dead cell nuclei was signiﬁcantly
increased after treatments with T3 and T4 (Fig. 2). In the con-
trol group, PI-positive reaction was noted only sporadically,
inside the follicular lumen where desquamated cells were pre-
sent (Fig. 3a). Apoptotic cells, mainly thyrocytes, observed
individually or in small groups in the wall of follicles subjected
to remodeling in both T3- and T4-treated groups, were more
prominent in the latter (Fig. 3b and c, respectively).
3.4. Electron microscopical study
Electron microscopy (Fig. 4) revealed that thyrocytes from the
control group in addition to a prominent nucleus, possessed
endoplasmic reticulum, Golgi complex placed at the lateral
margin of the cell and occasionally small dense granulesPlease cite this article in press as: Ali Rajab, N.M. et al., Histological and ultrastructural alterations of rat thyroid gland after short-term treatment with high doses of
thyroid hormones. Saudi Journal of Biological Sciences (2015), http://dx.doi.org/10.1016/j.sjbs.2015.05.006
Figure 3 PI-labeled nuclei (arrows) in the follicular lumen of
control rats (a) and within follicular wall of T3- and T4-treated
rats (b and c). Bar 40 lm (a–c).
Figure 4 Follicular epithelium of control, T3- and T4-treated
rats (a, b and c); t – thyrocyte, n – nucleus, m – mitochondrion, l –
lysosome, g – Golgi complex, er – endoplasmic reticulum, co –
colloid, e – erythrocyte in the capillary lumen. Insets show apical
pole of thyrocytes, with reduced and disorganized microvilli in T3-
and T4-treated rats. Bar 4 lm (a–c) and 1.5 lm (insets).
Thyroid gland in hyperthyroidism 5usually identiﬁed as lysosomes. Apically, thyrocytes had
numerous long, regular microvilli projecting into the follicular
lumen (Fig. 4a). After T3 treatment, thyrocytes became
slightly ﬂattened with irregular and fuzzy-like microvilli
(Fig. 4b). Treatment with T4 resulted in further ﬂattening of
follicular epithelium and shortening or even loss of microvilli
(Fig. 4c). Progressive stages of thyrocyte injury leading to
gradual dissolution of interfollicular wall might be seen in
places (Fig. 5a–f). Some thyrocytes had irregularly shaped
nuclei with condensed chromatin, and vesiculated cisterns of
endoplasmic reticulum located in the apical region of the cell
(Fig. 6a). Increased quantity of cell debris (Fig. 6a, inset) asPlease cite this article in press as: Ali Rajab, N.M. et al., Histological and ultrastructu
thyroid hormones. Saudi Journal of Biological Sciences (2015), http://dx.doi.org/10.well as individual erythrocytes within some follicles from T3-
and T4-treated animals were also noted (Fig. 6 b).
3.5. Results of stereological analysis
Stereological analysis conﬁrmed described visual observations
(Table 2). The volume density of colloid was increased in both
T3- and T4-treated groups, while the volume density of the fol-
licular epithelium was decreased. At the same time, the volume
density of follicles and interstitium remained nearly the same,ral alterations of rat thyroid gland after short-term treatment with high doses of
1016/j.sjbs.2015.05.006
Figure 5 Gradual injury of thyrocytes leading to dissolution of the interfollicular barrier. Note nuclear changes (n on a–e),
intracytoplasmic vesiculation (asterisk on c) and cellular debris (db) in the follicular lumen (d and e); arrowheads show thinning and
dissolution of interfollicular barrier. Bar 2 lm (a–e) and 5 lm (f).
Figure 6 Thyrocytes from animals treated with thyroid hormones, with deformed nuclei and vesiculated endoplasmic reticulum; inset
shows cell debris in the follicular lumen (a); erythrocytes in the colloid observed after treatments with T3 or T4 (b); n – nucleus, co –
colloid, e – erythrocyte. Bar 2 lm (a) and 5 lm (b).
Table 2 Results of stereological analysis of thyroid gland after treatment with thyroid hormones.
Control T3-treated T4-treated
Vv colloid (lm
0) 0.450 ± 0.0329 0.542 ± 0.0217* 0.615 ± 0.0258**
Vv follicular epithelium (lm
0) 0.348 ± 0.0172 0.248 ± 0.0031** 0.216 ± 0.0115***
Vv follicles (lm
0) 0.723 ± 0.0633 0.785 ± 0.0185 0.834 ± 0.0098
Vv interstitium (lm
0) 0.202 ± 0.0179 0.222 ± 0.0135 0.167 ± 0.0098
Thyroid activation index (Ia) 0.795 ± 0.0979 0.453 ± 0.0240
** 0.347 ± 0.0331**
Follicular cells height (lm) 8.26 ± 0.452 4.66 ± 0.368*** 4.51 ± 0.225***
* p< 0.05 vs. control.
** p< 0.01 vs. control.
*** p< 0.001 vs. control.
6 N.M. Ali Rajab et al.
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Thyroid gland in hyperthyroidism 7although some tendency toward enlargement of follicles on the
account of interstitium was noticed in the T4-treated group.
Height of follicular cells was reduced in both hormone-
treated groups. Finally, the thyroid activation index was signif-
icantly reduced in groups under treatment.4. Discussion
The improper thyroid function is associated not only with gen-
eral metabolic disturbance but also with a number of other
apparently unrelated health issues such as cardiac diseases,
lupus, rheumatoid arthritis, reproductive difﬁculties or dia-
betes (Duntas et al., 2011; Klein and Danzi, 2007; Krassas
et al., 2010; Kumar et al., 2012). In addition, thyroid hormones
disbalance may lead to emotional and behavioral disturbances
and impair patients’ everyday life. Therefore, any research on
the thyroid gland and its pathology has important medical as
well as social implications.
In this experiment we used a previously established model
of experimentally induced hyperthyroidism in rats (Petrovic
et al., 2003). Animals were treated with T3 or T4 in doses
which were highly above physiological replacement doses esti-
mated at 3 lg/kg b.w. for T3 (Dillmann et al., 1983) and
20 lg/kg b.w. for T4 (Berstein, 1980).
Expectedly, treatment with T3 signiﬁcantly elevated circu-
lating T3. T4 was markedly decreased as the result of T3 sup-
pressive effects on thyroid gland activity, mediated through
feedback inhibition of TRH and TSH release, at levels of
hypothalamus and pituitary, respectively (Belchetz et al.,
1978; Maruta and Greer, 1988; Saleh et al., 1998). At the same
time, it means that T3 in serum of T3-treated animals was
mainly exogenous.
In rats treated with supraphysiological doses of T4, concen-
trations of both T3 and T4 were elevated but the elevation was
not of the same magnitude. Namely, T3 increased for about
50%, while T4 concentration was more than doubled. This
suggests that peripheral T4 to T3 deiodination mechanisms
reached the level of saturation and could not be further inten-
siﬁed, even with excess of T4 as substrate. T4 concentration in
the blood remained steadily increased due to the overloaded
deiodination pathway.
Absolute and relative masses of the thyroid gland were
unchanged after both treatments, while stereological analysis
showed no differences in the relative abundance of main thy-
roid tissue compartments (parenchyma vs. interstitium)
between control and experimental groups. These results are
in disagreement with the data reported previously by Soukup
et al. (2001) who found markedly atrophied thyroids in rats
treated with high doses of thyroid hormones. However, consid-
erably shorter duration of our experiment (5 days vs. 6 month)
offers a good explanation for the absence of changes in men-
tioned parameters.
Within follicles, however, relative proportions of the thy-
roid epithelium and colloid were shifted in favor of colloid,
while the height of follicular cells was markedly reduced in
both treated groups. It is well known that the morphofunc-
tional status of each follicle is controlled not only by the
TSH level, but also by other factors including thyroglobulin
contained within the follicle. Depending on the stage of the fol-
licle physiological cycle, TSH may stimulate either expression
of thyroid-speciﬁc genes involved in thyroglobulin synthesis,Please cite this article in press as: Ali Rajab, N.M. et al., Histological and ultrastructu
thyroid hormones. Saudi Journal of Biological Sciences (2015), http://dx.doi.org/10.or reabsorption of colloid, its lysosomal degradation and
release of thyroid hormones (Suzuki et al., 2011). Follicles con-
taining large amounts of colloid, as in T3- and T4-treated
groups, are lined with thyrocytes in which synthesis of thy-
roglobulin is low (Suzuki et al., 1998, 1999, 2011). Normally,
under TSH-stimulation, such follicles should be engaged in
colloid resorption and hormones release. Although we did
not measure TSH levels, we estimated it indirectly, using the
thyroid activation index, which is known to be positively cor-
related with the level of TSH in circulation (Kalisˇnik, 1981;
Rajkovic et al., 2003, 2006). Thus, according to results
obtained for thyroid activation index, thyroids in both
hormone-treated groups were understimulated and in the state
of arrest. Cytologically, the disorganization and/or reduction
of microvilli, as well as signiﬁcantly reduced epithelial height,
provide further evidence for the functional quiescence of the
thyroid gland after thyroid hormone treatment.
In the control group the rare occurrence of desquamated
cells inside the follicles was noted after PI-staining. This ﬁnd-
ing in the absence of hormonal treatment is related to normal
basal thyroid cells turnover since it is known that, as in many
other organs, thyroid gland maintains its mass homeostasis by
sustained basal proliferation and apoptosis (Dremier et al.,
1994; Okayasu et al., 1995; Tamura et al., 1998). Apoptotic
cells are shed into the follicular lumen, subsequently being
removed by macrophages and the remaining thyrocytes
(Matsunaga et al., 1988). More frequently observed presence
of cell fragments and debris inside some low-epithelial and
irregularly shaped follicles of T3- and T4-treated rats, together
with PI-positive condensed nuclei within walls of such follicles,
point to loss of thyrocytes and remodeling/fusion of follicles.
Such intensiﬁed shedding of thyrocytes and their membrane-
bounded fragments was seen previously during involution of
the hyperplastic thyroid gland (Tachiwaki et al., 1990;
Tachiwaki and Wollman, 1982). Electron microscopy provided
more detailed insights on cell damages after treatments with
T3 or T4. Some thyrocytes within the follicular wall exhibited
signs of reversible cell injury, such as nuclear condensation and
vesiculation of cytoplasmic organelles. More advanced
destruction of thyrocytes sometimes even with abruption of
the follicular epithelium after thyroid hormone treatments
might be considered as the high grade tissue injury.
Occasionally, progressive damage expanded to nearby capillar-
ies, resulting in microhemorrhage indicated by the occurence
of erythrocytes inside the follicular lumen.
As it has been proposed earlier and mentioned above
herein, thyroglobulin accumulated inside the follicle is
involved in the regulation of thyrocyte activity, counterbalanc-
ing the TSH action (Suzuki et al., 1998, 1999, 2011). We
believe that excessive intrafollicular accumulation of thy-
roglobulin may produce increased pressure on thyrocytes,
deforming their cytoskeleton and generating pro-apoptotic sig-
nals (Field, 2010; Janmey, 1998). Thus, beside attenuation of
trophic TSH signals due to high circulating levels of thyroid
hormones, thyrocytes in hyperthyroid rats may have received
proapoptotic signals. The intensity of these signals, together
with functional status of the particular follicle, determines
the degree of epithelial damage ranging from mild degenera-
tion of individual lining cells to total destruction of follicular
wall and lumen fusion. Investigating the period needed for thy-
roid recovery after cessation of treatment was out of the scope
of this study. However, it has been shown previously thatral alterations of rat thyroid gland after short-term treatment with high doses of
1016/j.sjbs.2015.05.006
8 N.M. Ali Rajab et al.morphofunctional alterations of the thyroid gland caused by
noxious stimulation were not completely resolved even after
three months of repairing period (Rajkovic et al., 2003).
In summary, results of the present work demonstrate that
high doses of thyroid hormones cause serious damage of thy-
roid follicles in euthyroid rats, even after short-term treatment.
Observed changes are most probably based on the absence of
cytoprotective effects of TSH, together with reception of more
pronounced proapoptotic signals. Given that structural alter-
ations of the thyroid gland associated with dysfunction may
require an unpredictable recovery period, current ﬁndings
point to necessary caution needed when thyroid hormones
are used as therapeuticals.Acknowledgments
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